CD274 and neoplasm: To examine the ability of intratumoral PD-L1 expression levels to classify tumors as sensitive or insensitive to the anti-PD-L1 mAb, we measured PD-L1 mRNA expression in tumor samples by RNA sequencing and analyzed the ROC curve.